Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778–789.
   Web of Science ®Google Scholar
• Van Hemelrijck M, Jabbari H, Baade PD, et al. Global trends in incidence rates of primary adult liver cancers: a systematic review and meta-analysis. Front Oncol. 2020;10:171.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.
   PubMed Web of Science ®Google Scholar
• Daher S, Massarwa M, Benson AA, et al. Current and future treatment of hepatocellular carcinoma: an updated comprehensive review. J Clin Transl Hepatol. 2018;6:69–78.
   PubMed Web of Science ®Google Scholar
• Vogel A, Saborowski A. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treat Rev. 2020;82:101946.
   PubMed Web of Science ®Google Scholar
• Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3:673–683.
   PubMed Web of Science ®Google Scholar
• Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41–58.
   PubMed Web of Science ®Google Scholar
• Pedersen TR, Tobert JA. Simvastatin: a review. Expert Opin Pharmacother. 2004;5:2583–2596.
   PubMed Web of Science ®Google Scholar
• Duarte JA, de Barros ALB, Leite EA. The potential use of simvastatin for cancer treatment: a review. Biomed Pharmacother. 2021;141:111858.
   PubMed Web of Science ®Google Scholar
• Attia YM, Ewida H, Ahmed MS 2020. Chapter 8 - Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma. In: Drug Repurposing Cancer Ther Approaches Appl, editors. To K Cho W, pp. 213–229. Oxford: Academic Press.
   Google Scholar
• Wang S-T, Ho HJ, Lin J-T, et al. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Cell Death Dis. 2017;8:e2626.
   PubMed Web of Science ®Google Scholar
• Relja B, Meder F, Wang M, et al. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int J Oncol. 2011;38:879–885.
   PubMed Web of Science ®Google Scholar
• Feng J, Dai W, Mao Y, et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. J Exp Clin Cancer Res. 2020;39:24.
   PubMed Web of Science ®Google Scholar
• Du B, Shim JS. Targeting Epithelial–Mesenchymal Transition (EMT) to overcome drug resistance in cancer. Molecules. 2016;21:965.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–1428.
   PubMed Web of Science ®Google Scholar
• Karimi Roshan M, Soltani A, Soleimani A, et al. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie. 2019;165:229–234.
   PubMed Web of Science ®Google Scholar
• Mziaut H, Henniger G, Ganss K, et al. MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling. Mol Metab. 2020;31:150–162.
   PubMed Web of Science ®Google Scholar
• Mathur P, Rawal S, Patel B, et al. Oral delivery of anticancer agents using nanoparticulate drug delivery system. Curr Drug Metab. 2019;20:1132–1140.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh H, Atyabi F, Dinarvand R, et al. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine. 2012;7:1851–1863.
   PubMed Web of Science ®Google Scholar
• Ying K, Bai B, Gao X, et al. Orally administrable therapeutic nanoparticles for the treatment of colorectal cancer. Front Bioeng Biotechnol. 2021;9. doi:10.3389/fbioe.2021.670124.
   Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653–664.
   PubMed Web of Science ®Google Scholar
• Parodi A, Buzaeva P, Nigovora D, et al. Nanomedicine for increasing the oral bioavailability of cancer treatments. J Nanobiotechnology. 2021;19:354.
   PubMed Web of Science ®Google Scholar
• Islam MA, Barua S, Barua D. A multiscale modeling study of particle size effects on the tissue penetration efficacy of drug-delivery nanoparticles. BMC Syst Biol. 2017;11:113.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BYS, Rutka JT, et al. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145–150.
   PubMed Web of Science ®Google Scholar
• Foroozandeh P, Aziz AA. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 2018;13:339.
   PubMed Web of Science ®Google Scholar
• Zhu M, Nie G, Meng H, et al. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res. 2013;46:622–631.
   PubMed Web of Science ®Google Scholar
• Perrault SD, Walkey C, Jennings T, et al. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9:1909–1915.
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9:223–243.
   PubMed Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379:201–209.
   PubMed Web of Science ®Google Scholar
• Moura RP, Pacheco C, Pêgo AP, et al. Lipid nanocapsules to enhance drug bioavailability to the central nervous system. J Control Release. 2020;322:390–400.
   PubMed Web of Science ®Google Scholar
• Mouzouvi CRA, Umerska A, Bigot AK, et al. Surface active properties of lipid nanocapsules. PLoS ONE. 2017;12:e0179211.
   PubMed Web of Science ®Google Scholar
• Tavares Luiz M, Delello Di Filippo L, Carolina Alves R, et al. The use of TPGS in drug delivery systems to overcome biological barriers. Eur Polym J. 2021;142:110129.
   Web of Science ®Google Scholar
• Zhang Z, Mei L, Feng S-S. Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine. 2012;7:1645–1647.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, et al. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018;8:464–485.
   PubMed Web of Science ®Google Scholar
• Tan S, Zou C, Zhang W, et al. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv. 2017;24:1831–1842.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. The influence of lipid nanocapsule composition on their size distribution. Eur J Pharm Sci. 2003;18:55–61.
   PubMed Web of Science ®Google Scholar
• Morille M, Montier T, Legras P, et al. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials. 2010;31:321–329.
   PubMed Web of Science ®Google Scholar
• Hu K, Cao S, Hu F, et al. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine. 2012;7:3537–3545.
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, et al. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces. 2012;97:109–116.
   PubMed Web of Science ®Google Scholar
• Mahmoud KY, Elhesaisy NA, Rashed AR, et al. Exploring the potential of intranasally administered naturally occurring quercetin loaded into polymeric nanocapsules as a novel platform for the treatment of anxiety. Sci Rep. 2023;13:510.
   PubMedGoogle Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Liang C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–333.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Parayath NN, Nehoff H, Müller P, et al. Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells. Int J Nanomedicine. 2015;10:4653–4667.
   PubMed Web of Science ®Google Scholar
• El-Sheridy NA, El-Moslemany RM, Ramadan AA, et al. Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules. Drug Deliv. 2021;28:906–919.
   PubMed Web of Science ®Google Scholar
• Jaganathan SK, Mondhe D, Wani ZA, et al. Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. Ferrone S, editor J Biomed Biotechnol. 2010;2010:989163.
   PubMedGoogle Scholar
• Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem Off J Histochem Soc. 1981;29:577–580.
   PubMed Web of Science ®Google Scholar
• Rahat I, Imam SS, Rizwanullah M, et al. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments. Drug Deliv. 2021;28:973–984.
   PubMed Web of Science ®Google Scholar
• Jurga N, Przybylska D, Kamiński P, et al. Improvement of ligand-free modification strategy to obtain water-stable up-converting nanoparticles with bright emission and high reaction yield. Sci Rep. 2021;11:18846.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tavakoli N, Salamat FA. Enhanced dissolution rate of simvastatin using spherical crystallization technique. Pharm Dev Technol. 2011;16:529–535.
   PubMed Web of Science ®Google Scholar
• Kulhari H, Pooja D, Prajapati SK, et al. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm. 2011;405:203–209.
   PubMed Web of Science ®Google Scholar
• Kiani A, Fathi M, Ghasemi SM. Production of novel vitamin D3 loaded lipid nanocapsules for milk fortification. Int J Food Prop. 2017;20:2466–2476.
   Web of Science ®Google Scholar
• Maurya VK, Aggarwal M. A phase inversion based nanoemulsion fabrication process to encapsulate vitamin D3 for food applications. J Steroid Biochem Mol Biol. 2019;190:88–98.
   PubMed Web of Science ®Google Scholar
• Permana AD, Utami RN, Courtenay AJ, et al. Phytosomal nanocarriers as platforms for improved delivery of natural antioxidant and photoprotective compounds in propolis: an approach for enhanced both dissolution behaviour in biorelevant media and skin retention profiles. J Photochem Photobiol B Biol. 2020;205:111846.
   PubMed Web of Science ®Google Scholar
• Khare V, Sakarchi WA, Gupta PN, et al. Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy. RSC Adv. 2016;6:60126–60137.
   Web of Science ®Google Scholar
• Perez-Ruiz AG, Ganem A, Olivares-Corichi IM, et al. Lecithin–chitosan–tpgs nanoparticles as nanocarriers of (−)-epicatechin enhanced its anticancer activity in breast cancer cells. RSC Adv. 2018;8:34773–34782.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19:875–880.
   PubMed Web of Science ®Google Scholar
• Zhai Q, Li H, Song Y, et al. Preparation and optimization lipid nanocapsules to enhance the antitumor efficacy of cisplatin in hepatocellular carcinoma HepG2 cells. AAPS Pharm Sci Tech. 2018;19:2048–2057.
   PubMed Web of Science ®Google Scholar
• Safwat S, Hathout RM, Ishak RA, et al. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment. J Liposome Res. 2017;27:1–10.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface. Int J Pharm. 2002;242:167–170.
   PubMedGoogle Scholar
• Paillard A, Hindré F, Vignes-Colombeix C, et al. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials. 2010;31:7542–7554.
   PubMed Web of Science ®Google Scholar
• Hirsjärvi S, Bastiat G, Saulnier P, et al. Evaluation of surface deformability of lipid nanocapsules by drop tensiometer technique, and its experimental assessment by dialysis and tangential flow filtration. Int J Pharm. 2012;434:460–467.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Z, Liu O. Simultaneous determination of kolliphor HS15 and miglyol 812 in microemulsion formulation by ultra-high performance liquid chromatography coupled with nano quantity analyte detector. J Pharm Anal. 2016;6:11–17.
   PubMedGoogle Scholar
• Ohshima H. Electrophoretic mobility of a charged spherical colloidal particle covered with an uncharged polymer layer. Electrophoresis. 2002;23:1995–2000.
   PubMed Web of Science ®Google Scholar
• Vonarbourg A, Saulnier P, Passirani C, et al. Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis. 2005;26:2066–2075.
   PubMed Web of Science ®Google Scholar
• Rapalli VK, Kaul V, Waghule T, et al. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci. 2020;152:105438.
   PubMed Web of Science ®Google Scholar
• Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or Lipophilic Statins? Front Cardiovasc Med. 2021;8. DOI:10.3389/fcvm.2021.687585
   PubMed Web of Science ®Google Scholar
• Ezzeldeen Y, Swidan S, ElMeshad A, et al. Green synthesized honokiol transfersomes relieve the immunosuppressive and stem-like cell characteristics of the aggressive B16F10 melanoma. Int J Nanomedicine. 2021;16:5693–5712.
   PubMed Web of Science ®Google Scholar
• Maji R, Dey NS, Satapathy BS, et al. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomedicine. 2014;9:3107–3118.
   PubMed Web of Science ®Google Scholar
• Gordon SH, Harry-O’kuru RE, Mohamed AA. Elimination of interference from water in KBr disk FT-IR spectra of solid biomaterials by chemometrics solved with kinetic modeling. Talanta. 2017;174:587–598.
   PubMed Web of Science ®Google Scholar
• Mohsen K, Azzazy HME, Allam NK, et al. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: in vitro optimization and in vivo pharmacokinetic study. Mater Sci Eng C. 2020;116:111236.
   PubMed Web of Science ®Google Scholar
• Urimi D, Widenbring R, Pérez García RO, et al. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery. Int J Pharm. 2021;602:120640.
   PubMedGoogle Scholar
• Lamprecht A, Bouligand Y, Benoit J-P. New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release. 2002;84:59–68.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003;24:4283–4300.
   PubMed Web of Science ®Google Scholar
• Roger E, Gimel J-C, Bensley C, et al. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model. J Control Release. 2017;253:11–18.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit J-P. The gastrointestinal stability of lipid nanocapsules. Int J Pharm. 2009;379:260–265.
   PubMed Web of Science ®Google Scholar
• Ali SH, Sulaiman GM, Al-Halbosiy MMF, et al. Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity. Artif Cells Nanomed Biotechnol. 2019;47:378–394.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662–668.
   PubMed Web of Science ®Google Scholar
• Lu F, Wu S-H, Hung Y, et al. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5:1408–1413.
   PubMed Web of Science ®Google Scholar
• Osaki F, Kanamori T, Sando S, et al. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc. 2004;126:6520–6521.
   PubMed Web of Science ®Google Scholar
• Xie F, Liu J, Li C, et al. Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. Oncol Lett. 2016;11:3377–3383.
   PubMed Web of Science ®Google Scholar
• Jin Y, Xu K, Chen Q, et al. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. Exp Cell Res. 2018;362:362–369.
   PubMed Web of Science ®Google Scholar
• Chen W-W, Qi J-W, Hang Y, et al. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA. Eur Rev Med Pharmacol Sci. 2020;24:4263–4270.
   PubMed Web of Science ®Google Scholar
• Wang T, Seah S, Loh X, et al. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. Oncotarget. 2016;7:2532–2544.
   PubMedGoogle Scholar
• Banerjee A, Qi J, Gogoi R, et al. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176–185.
   PubMed Web of Science ®Google Scholar
• Wong AD, Ye M, Ulmschneider MB, et al. Quantitative Analysis of the Enhanced Permeation and Retention (EPR) effect. PLoS ONE. 2015;10:e0123461.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657–3666.
   PubMed Web of Science ®Google Scholar
• Tang L, Yang X, Yin Q, et al. Investigating the optimal size of anticancer nanomedicine. Proc Natl Acad Sci. 2014;111:15344–15349.
   PubMed Web of Science ®Google Scholar
• Liu GW, Pippin JW, Eng DG, et al. Nanoparticles exhibit greater accumulation in kidney glomeruli during experimental glomerular kidney disease. Physiol Rep. 2020;8:e14545.
   PubMed Web of Science ®Google Scholar